Rainer Blasczyk height - How tall is Rainer Blasczyk?

Rainer Blasczyk was born on 8 January, 1962 in Germany, is a physician. At 58 years old, Rainer Blasczyk height not available right now. We will update Rainer Blasczyk's height soon as possible.

Now We discover Rainer Blasczyk's Biography, Age, Physical Stats, Dating/Affairs, Family and career updates. Learn How rich is He in this year and how He spends money? Also learn how He earned most of net worth at the age of 60 years old?

Popular As Rainer Blasczyk
Occupation physician
Rainer Blasczyk Age 60 years old
Zodiac Sign Capricorn
Born 8 January 1962
Birthday 8 January
Birthplace Germany
Nationality Germany

We recommend you to check the complete list of Famous People born on 8 January. He is a member of famous Physician with the age 60 years old group.

Rainer Blasczyk Weight & Measurements

Physical Status
Weight Not Available
Body Measurements Not Available
Eye Color Not Available
Hair Color Not Available

Dating & Relationship status

He is currently single. He is not dating anyone. We don't have much information about He's past relationship and any previous engaged. According to our Database, He has no children.

Family
Parents Not Available
Wife Not Available
Sibling Not Available
Children Not Available

Rainer Blasczyk Net Worth

He net worth has been growing significantly in 2021-22. So, how much is Rainer Blasczyk worth at the age of 60 years old? Rainer Blasczyk’s income source is mostly from being a successful Physician. He is from Germany. We have estimated Rainer Blasczyk's net worth , money, salary, income, and assets.

Net Worth in 2022 $1 Million - $5 Million
Salary in 2022 Under Review
Net Worth in 2021 Pending
Salary in 2021 Under Review
House Not Available
Cars Not Available
Source of Income Physician

Rainer Blasczyk Social Network

Instagram
Linkedin
Twitter
Facebook
Wikipedia Rainer Blasczyk Wikipedia
Imdb

Timeline

2018

The scientific work of Blasczyk is focused on the alloimmune response in transplantation and strategies to combat organ rejection. Together with Constanca Figueiredo, he initiated the research on transplant engineering by genetically modifying allografts during their inevitable ex vivo period after explantation in such a way that they become permanently invisible to the recipient's immune system and are prevented from rejection. Since 2018, Blasczyk has been head of the research consortium on invisible organs, an innovation network funded jointly by the European Regional Development Fund and the state of Lower Saxony, Germany.

2006

Blasczyk was president of the German Society for Immunogenetics (DGI) from 2006-2008 and 2012-2014, president of the German Society of Transfusion Medicine and Immunohematology (DGTI) from 2015-2016, served as a board member of the European Federation for Immunogenetics (EFI) from 2008-2010 and as transplantation specialist on its advisory board from 2009-2019. Blasczyk is editor of the journal Transfusion Medicine and member of the editorial board of the journal HLA. From 2016-2019, he has been an appointed member of the Advisory Board on Blood Products of the German Federal Ministry of Health.

1998

Blasczyk holds a professorship in the subject at Hannover Medical School and the directorship of the institute of transfusion medicine and transplant engineering since 1998. He graduated in Medicine at the University of Essen in 1987 and began his clinical education as a junior clinician in abdominal surgery at the University of Marburg, where his interest in organ transplantation evolved. In 1988, he moved to the institute of immunology at the University of Essen, where he started to work in the field of histocompatibility and immunogenetics. From 1991 to 1993 he continued his clinical education in hematology and oncology at the University of Duesseldorf. Following these clinical years he returned to the field of immunology in 1993 at the institute of transfusion medicine, Humboldt-University of Berlin, where he started to work on molecular immunogenetics.

1962

Rainer Blasczyk (born January 8, 1962 in Castrop-Rauxel) is a German physician for transfusion medicine specialized in histocompatibility and immunogenetics in the field of organ transplantation. He is known for the development of genetic engineering of allografts to prevent organ rejection.